WEBPune, August 13, 2024: Emcure Pharmaceuticals (SE:544210, NSE: EMURE) today announced its unaudited consolidated financial results for the quarter ended June 30th, 2024. The company demonstrated robust performance across geographies, achieving significant growth in both revenue and EITDA.
Emcure Pharmaceuticals IPO: Shark Tank’s Namita Thapar likely …
WEBJul 2, 2024 — Emcure Pharmaceuticals IPO, which is set to start with a share sale tomorrow, Wednesday, July 3, is estimated to bring in about ₹ 127.87 crore for Namita Thapar, a well-known Shark Tank India...
India's Emcure Pharma plans 2024 IPO, hires JP Morgan, Jefferies
WEBMUMBAI, Sept 25 (Reuters) - India's Emcure Pharmaceuticals aims to raise $400-$500 million from an initial public offering planned for next year, two sources said, reviving listing plans the...
Emcure Pharma IPO: GMP jumps as allotment date likely today.
WEBJul 8, 2024 — Emcure Pharma IPO: The bidding for the initial public offering (IPO) of Emcure Pharmaceuticals Limited concluded on Friday last week, with the public issue worth ₹ 1,952.03 crore receiving a...
Emcure Pharmaceuticals IPO: Anchor Allocation at 29.67%
WEBJul 8, 2024 — Emcure Pharmaceuticals Ltd will test the appetite for private sector new age pharma stocks in India. The credits to the demat account to the extent of shares allotted will happen by the close of 09th July 2024 under ISIN (INE168P01015).
Namita Thapar's Emcure Pharmaceuticals IPO opens today: All …
WEBThe initial public offering (IPO) of Emcure Pharmaceuticals opens for subscription today (July 3). Ahead of the issue, the company's shares were trading at a premium of ₹ 265 in the unlisted...
Bain-backed Emcure Pharmaceuticals eyes $672 mln IPO - source
WEBBENGALURU, Aug 19 (Reuters) - India's Emcure Pharmaceuticals has filed draft papers with the market regulator for an initial public offering, which a source with direct knowledge of the matter...
Emcure Pharma IPO: Issue subscribed 1.32 times on Day 1 ... - Moneycontrol
WEBJul 3, 2024 — Emcure Pharmaceuticals public issue witnessed a good start on the first day of bidding on July 3, led by non-institutional and retail investors. The company's Rs 1,952.03-crore public offer was...
Emcure Pharmaceuticals: Emcure Q1 Results: Net profit rises …
WEBAug 13, 2024 — Emcure Pharmaceuticals saw an 8.2% rise in net profit for Q1FY25, reaching Rs 153 crore due to strong sales in India and abroad. Revenue from operations increased by 16.6% to Rs 1,815 crore. The company reported growth across Europe and Canada, emphasizing its successful integration of Sanofi's cardiovascular brands.
Newsroom | Emcure Pharmaceuticals
WEBStay updated with all the latest press releases & news about Emcure Pharmaceuticals, Gennova Biopharmaceuticals Ltd & Zuventus Healthcare Ltd and know whenever they are mentioned in the news